These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38820447)

  • 21. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis.
    Tao Y; XueSong Z; Xiao Y; YueZhi K; Xin W; YanPing T; Lei W; YongPing F
    Clin Neurol Neurosurg; 2021 Aug; 207():106805. PubMed ID: 34280674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative oxygenation venography from MRI phase.
    Fan AP; Bilgic B; Gagnon L; Witzel T; Bhat H; Rosen BR; Adalsteinsson E
    Magn Reson Med; 2014 Jul; 72(1):149-59. PubMed ID: 24006229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis.
    Yarnykh VL; Bowen JD; Samsonov A; Repovic P; Mayadev A; Qian P; Gangadharan B; Keogh BP; Maravilla KR; Jung Henson LK
    Radiology; 2015 Jan; 274(1):210-20. PubMed ID: 25208343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional connectivity dynamics reflect disability and multi-domain clinical impairment in patients with relapsing-remitting multiple sclerosis.
    Romanello A; Krohn S; von Schwanenflug N; Chien C; Bellmann-Strobl J; Ruprecht K; Paul F; Finke C
    Neuroimage Clin; 2022; 36():103203. PubMed ID: 36179389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.
    Hojjat SP; Cantrell CG; Vitorino R; Feinstein A; Shirzadi Z; MacIntosh BJ; Crane DE; Zhang L; Morrow SA; Lee L; O'Connor P; Carroll TJ; Aviv RI
    Mult Scler; 2016 Oct; 22(11):1421-1428. PubMed ID: 26754799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.
    Laffon M; Malandain G; Joly H; Cohen M; Lebrun C
    Neurol Ther; 2014 Dec; 3(2):113-22. PubMed ID: 26000227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-reported outcome measurements in a selective cohort of relapsing-remitting multiple sclerosis patients: relationships with physical disability, cognitive impairment, and MRI-derived metrics.
    London F; El Sankari S; De Haan A; Benyahia Z; Landenne G; Duprez T; van Pesch V
    Acta Neurol Belg; 2023 Jun; 123(3):1049-1059. PubMed ID: 36877357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corpus callosum axon diameter relates to cognitive impairment in multiple sclerosis.
    Huang SY; Fan Q; Machado N; Eloyan A; Bireley JD; Russo AW; Tobyne SM; Patel KR; Brewer K; Rapaport SF; Nummenmaa A; Witzel T; Sherman JC; Wald LL; Klawiter EC
    Ann Clin Transl Neurol; 2019 May; 6(5):882-892. PubMed ID: 31139686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T.
    Inglese M; Park SJ; Johnson G; Babb JS; Miles L; Jaggi H; Herbert J; Grossman RI
    Arch Neurol; 2007 Feb; 64(2):196-202. PubMed ID: 17296835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
    Dong X; Xu G; Wang J; Yin N; Meng N
    Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement and correction of the bulk magnetic susceptibility effects of fat: application in venous oxygen saturation imaging.
    Yang E; Kirkham AA; Grenier J; Thompson RB
    Magn Reson Med; 2019 May; 81(5):3124-3137. PubMed ID: 30549088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic Changes of Asymmetric Cortical Veins Relate to Neurologic Prognosis in Acute Ischemic Stroke.
    Lu X; Luo Y; Fawaz M; Zhu C; Chai C; Wu G; Wang H; Liu J; Zou Y; Gong Y; Haacke EM; Xia S
    Radiology; 2021 Dec; 301(3):672-681. PubMed ID: 34581624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal nerve fiber and ganglion cell complex layer thicknesses mirror brain atrophy in patients with relapsing-remitting multiple sclerosis.
    Glasner P; Sabisz A; Chylińska M; Komendziński J; Wyszomirski A; Karaszewski B
    Restor Neurol Neurosci; 2022; 40(1):35-42. PubMed ID: 35180139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis.
    Fulton JC; Grossman RI; Udupa J; Mannon LJ; Grossman M; Wei L; Polansky M; Kolson DL
    AJNR Am J Neuroradiol; 1999; 20(10):1951-5. PubMed ID: 10588124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
    Hojjat SP; Cantrell CG; Carroll TJ; Vitorino R; Feinstein A; Zhang L; Symons SP; Morrow SA; Lee L; O'Connor P; Aviv RI
    Mult Scler; 2016 Nov; 22(13):1685-1694. PubMed ID: 26846987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis.
    Trenova AG; Slavov GS; Draganova-Filipova MN; Mateva NG; Manova MG; Miteva LD; Stanilova SA
    Neurol Res; 2018 Mar; 40(3):153-159. PubMed ID: 29297273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Quantitative Cerebral Blood Flow Measurements Performed by Bookend Dynamic Susceptibility Contrast and Arterial Spin-Labeling MRI in Relapsing-Remitting Multiple Sclerosis.
    D'Ortenzio RM; Hojjat SP; Vitorino R; Cantrell CG; Lee L; Feinstein A; O'Connor P; Carroll TJ; Aviv RI
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2265-2272. PubMed ID: 27686489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis.
    Zivadinov R; Tavazzi E; Bergsland N; Hagemeier J; Lin F; Dwyer MG; Carl E; Kolb C; Hojnacki D; Ramasamy D; Durfee J; Weinstock-Guttman B; Schweser F
    Radiology; 2018 Nov; 289(2):487-496. PubMed ID: 30015589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.